JPRN-UMIN000039133招募中未知
Establishment of disease specific iPS cells and analysis of the pathology - disease specific iPS cells
ational Hospital Organization, Nagara Medical Center0 个研究点目标入组 40 人开始时间: 2020年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are judged inappropriate by the doctor's judgment. Patients infected with human immunodeficiency virus, human hepatitis B virus, and human hepatitis C virus.
研究者
相似试验
招募中
不适用
Establishment of human iPS cells differentiation from TOFtetralogy of fallotJPRN-UMIN000031786Saitama medical university International medical Center20
已完成
不适用
Patient-specific iPS cells for cardiovascular diseasesCardiovascular diseasesJPRN-UMIN000012040Okayama University Hospital50
已完成
不适用
Development of induced pluripotent stem (iPS) cells from patients with muscular disorders for the study of the pathogenesis of the diseases and development of therapiesSkeletal muscle disease Myotonic dystrophy Muscular dystrophiesJPRN-UMIN000008958Osaka University Graduate School of Medicine20
已完成
不适用
Patient Specific Induced Pluripotency Stem Cells (PSiPS)Hepatic DisordersEye DisordersNCT00953693Royan Institute15
招募中
不适用
Research on the development of the iPS cell stock derived from voluntary HLA homozygoues donor who have donated bone marrow etc.healthy adultJPRN-UMIN000016026Center for iPS Cell Research and Application (CiRA), Kyoto University20
